Reading the SEDAR filing you posted makes MacNallys statements in November even more unbelievable..
"There is a consistent pattern of findings already emerging from our preclinical studies. First, we're being told by experienced robotic surgeons that the user requirements which we finalize in a milestone earlier this year are right on target. These surgeons are telling us that the system is useful in its present form as they've been able to perform the basic functions of surgery, including tissue manipulation and approximation, grasping, cutting, suturing, and coagulation with our advanced prototypes. As a result, there is growing excitement for Titan Medical to be the next great robotic surgery company"
"...And most significantly, we expect to prepare our regulatory submissions in the U.S. and Europe and to submit 510(k) and CE Mark applications before the end of 2018"
What balls.....